3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast CancerHR-positive, HER2-negative Breast NeoplasmsActive, not recruitingPhase 32026-01-07NCT05365178
The Fever Clinic Acute Respiratory CohortBody Temperature Changes, Community-Acquired Infections, Community-Acquired Pneumonia, Disease Attributes, Disease Progression, Fever, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, pneumonia, respiratory system disorder, respiratory tract infectious disorderRecruitingNot stated2025-12-12NCT07278700
Effects of Huperzine a on Presbycusis(Δ,kHz, DB,MMSE, AD)Cognition Disorders, Cognitive Dysfunction, Ear Diseases, Hearing Loss, Sensorineural, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, cognitive disorder, hearing disorder, hearing loss disorder, nervous system disorder, otorhinolaryngologic disease, presbycusis, psychiatric disorder, tinnitusEnrolling by invitationNot applicable2024-10-01NCT03101722